Laura A. Williams, Chief Patient Officer at ARDELYX, INC. (ARDX), sold 80,000 shares at $6.12 ($490K) on 2025-08-26, disclosed to the SEC on 2025-08-28.
Scheduled sale ($490k) by Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.12 | 30,000 | $184K | 37.5% |
| 2 | $6.12 | 50,000 | $306K | 62.5% |
| Total | $6.12 avg | 80,000 | $490K | 100% |
| Filing → |
| ARDX | SELL | 2026-05-22 | $44K | — | Filing → |
| ARDX | SELL | 2026-02-23 | $48K | — | Filing → |
| ARDX | SELL | 2026-01-09 | $698K | — | Filing → |